XML 24 R13.htm IDEA: XBRL DOCUMENT v3.24.4
INVESTMENTS AND FAIR VALUE MEASUREMENTS
6 Months Ended
Oct. 31, 2024
INVESTMENTS AND FAIR VALUE MEASUREMENTS  
INVESTMENTS AND FAIR VALUE MEASUREMENTS

 5.  INVESTMENTS AND FAIR VALUE MEASUREMENTS

We invest surplus funds in excess of operational requirements in a diversified portfolio of marketable securities, with the objectives of delivering competitive returns, maintaining a high degree of liquidity, and seeking to avoid the permanent impairment of principal. A summary of our investments in marketable equity and debt securities as of October 31, 2024, is as follows:


Investments - current were as follows (in thousands):

 


October 31, 2024


 


April 30, 2024


Marketable equity securities

$

44,413


 

$

  50,496


U.S. treasury securities


34,396


 


42,352


Short-term investments

$

78,809


 

$

92,848


Investments- noncurrent were as follows (in thousands):

 


October 31, 2024


 


April 30, 2024


U.S. treasury securities

$

   16,101


 

$

    19,747


Corporate bonds


21,246


 


26,798


Investments- noncurrent

$

37,347


 

$

46,545


Marketable Securities

 

Marketable securities as of October 31, 2024 and April 30, 2024 consisted of the following (in thousands):



October 31, 2024




Cost or Amortized Cost
 
Unrealized Gains
 
Unrealized Losses
 
Fair Value

Marketable equity securities
















Equity securities

$

45,339



$

2,802



$

(3,728

)


$

44,413


Marketable debt securities
















U.S. treasury securities


49,749




748






50,497


Corporate bonds


20,584




684




(22

)



21,246


Total marketable debt securities


70,333




 1,432




(22

)



 71,743



$

115,672



$

4,234



$

(3,750

)


$

116,156


 



April 30, 2024




Cost or Amortized Cost




Unrealized Gains




Unrealized Losses




Fair Value


Marketable equity securities
















Equity securities

$

 50,645



$

5,656



$

(5,805

)


$

50,496


Marketable debt securities
















U.S. treasury securities


61,306




825




(32

)



62,099


Corporate bonds


25,695




1,151




(48

)



26,798


Total marketable debt securities


 87,001




1,976




(80

)



88,897



$

137,646



$

 7,632



$

(5,885

)


$

 139,393



The amortized costs and fair value of our marketable debt securities, by contractual maturity, as of October 31, 2024 (in thousands) are as follows: 

 



October 31, 2024




Amortized Cost




Fair Value


Less than 1 year

$

 33,842



$

34,396


1 to 5 years


36,491




37,347


Total

$

 70,333



$

71,743



         As of October 31, 2024, the fair value of corporate bonds with unrealized loss position was $10.8 million, with an aggregated loss of $22,000.  There were no U.S.treasury with unrealized loss position at October 31. 2024.As of April 30, 2024, the fair value of available-for-sale debt securities in unrealized loss position for corporate bonds and U.S. treasury securities were $5.6 million and $25.2 million, respectively, with an aggregated loss of $0.1 million. For all available-for-sale debt securities that were in unrealized loss positions, we have determined that it is more likely than not we will hold the securities until maturity or a recovery of the cost basis. We had no credit-related impairment loss as of October 31, 2024 and April 30, 2024.


Derivative Financial Instruments

 

Our derivative instruments consisted of call and put options sold at their fair value as of the balance sheet date. These derivative instruments are reported as Other current liabilities on our Condensed Consolidated Balance Sheets as of October 31, 2024 and April 30, 2024 (in thousands):

 



October 31, 2024




Cost




Unrealized Gains




Fair Value


Derivative instruments

$

7,145



$

(3,251

)


$

3,894



$

7,145



$

(3,251

)


$

3,894


 



April 30, 2024




Cost




Unrealized Gains




Fair Value


Derivative instruments

$

7,935



$

(2,495

)


$

5,440



$

7,935



$

(2,495

)


$

5,440



A summary of realized and unrealized gains and losses from our equity securities and derivative instruments and realized gains and losses from our marketable debt securities are as follows (in thousands):


One Month Ended

Three Months Ended
Six Months Ended

July 31, 2024

October 31, 2024

June 30, 2023

October 31, 2024

June 30, 2023

Net unrealized gains (losses) recognized on marketable equity securities

$ 2,839

$

(2,407

)


$

(1,255

)
$ (776 )
$ 759

Net realized gains recognized on marketable equity securities


704


 834



4,561



3,941


6,230

Net unrealized gains (losses) recognized on derivative instruments


1,128


1,282



(91

)

757

(194 )

Net realized gains recognized on derivative instruments


172


866



1,520




3,462


2,237

Net realized gains recognized on marketable debt securities


1,056


35



217




1,308


217

Total net gains recognized in interest and other income (loss), net

$ 5,899

$

 610


$

4,952


$ 8,692

$ 9,249

Fair Value Measurements

Our financial instruments include cash and cash equivalents, receivables, accrued liabilities and accounts payable. The fair value of cash and cash equivalents, receivables, accrued liabilities and accounts payable approximates their carrying values because of the short-term nature of these instruments, which are all considered Level 1. The fair value of long-term debt approximates its carrying value.

Our financial instruments measured at fair value on a recurring basis consisted of U.S. treasury securities, equity securities, corporate bonds and derivatives. Equity securities are classified within Level 1 of the fair value hierarchy as they are valued based on quoted market price in an active market. U.S. treasury securities, corporate bonds and derivative instruments are valued based on quoted prices in markets that are less active, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency are generally classified within Level 2 of the fair value hierarchy.

Financial instruments valued based on unobservable inputs which reflect the reporting entity’s own assumptions or data that market participants would use in valuing an instrument are generally classified within Level 3 of the fair value hierarchy. We did not hold Level 3 financial instruments as of October 31, 2024, and April 30, 2024.


Financial instruments measured at fair value on a recurring basis as of October 31, 2024 and April 30, 2024 are classified based on the valuation technique in the table below (in thousands):



October 31, 2024








Fair Value Measurements Using








Quoted Prices in Active Markets for Identical Assets (Level 1)




Significant Other Observable Inputs (Level 2)




Significant Unobservable Inputs (Level 3)




Total


Assets:
















U.S. treasury securities 

$

 —



$

 50,497



$

 —



$

50,497


Equity securities


44,413




 —







 44,413


Corporate bonds


 —




 21,246







 21,246


Total assets at fair value

$

44,413



$

 71,743



$



$

116,156


















Liabilities
















Derivative instruments

$

 —



$

 3,894



$



$

3,894


Total liabilities at fair value

$

 —



$

 3,894



$



$

3,894





April 30, 2024








Fair Value Measurements Using








Quoted Prices in Active Markets for Identical Assets (Level 1)




Significant Other Observable Inputs (Level 2)




Significant Unobservable Inputs (Level 3)




Total


Assets:
















U.S. treasury securities

$



$

  62,099



$


$

62,099


Equity securities


 50,496







 —




 50,496


Corporate bonds


8,220




18,578




  —




26,798


Total assets at fair value

$

58,716



$

80,677



$



$

139,393


















Liabilities
















Derivative instruments

$

 —



$

 5,440



$

  —



$

  5,440


Total liabilities at fair value

$

 —



$

  5,440



$

 —



$

5,440